SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029668
Filing Date
2019-08-07
Accepted
2019-08-07 08:04:10
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q - JUNE 30, 2019 alna-10q_20190630.htm 10-Q 2099555
2 EX-31.1 alna-ex311_6.htm EX-31.1 16715
3 EX-31.2 alna-ex312_8.htm EX-31.2 16706
4 EX-32.1 alna-ex321_7.htm EX-32.1 10200
  Complete submission text file 0001564590-19-029668.txt   5310406

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alna-20190630.xml EX-101.INS 867916
6 XBRL TAXONOMY EXTENSION SCHEMA alna-20190630.xsd EX-101.SCH 36166
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alna-20190630_cal.xml EX-101.CAL 38852
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alna-20190630_def.xml EX-101.DEF 121036
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alna-20190630_lab.xml EX-101.LAB 303507
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alna-20190630_pre.xml EX-101.PRE 229985
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38268 | Film No.: 191003880
SIC: 2836 Biological Products, (No Diagnostic Substances)